com/reports/c18404 ) has announced the addition
of US High Net Worth 2004 to their offering.

illustrating converges

Utilizes our proprietary Global Wealth Model and in-depth interviews with
senior executives from some of the top 15 US wealth managers.

construct interpretative

iAdvocate, by providing a working platform
for both management and scientific liaisons, creates a seamless working
environment acutely focused on key objectives and opportunities.
"We are very excited how iAdvocate can transform the management of thought
leader relationships for our pharmaceutical partners," commented Moish Tov, CEO
of Skila.skila.

alternates emergent

J. By combining
both management and workflow tools, all stakeholders can access information and
effectively manage the process to insure a high impact.

reflexivity regard

researchandmarkets .com/cgi-bin/prnh/20040820/RESEARCH )
As in many markets, the past few years have been a testing time for US
wealth managers as both personal wealth and the resulting revenues have been
hit by the global downturn and the bursting of the tech bubble.

Highlights
There were 8.

qualitative intentions

Skila 's solutions help the pharmaceutical industry increase their marketing
and brand effectiveness.
(Photo: NewsCom: http://www.5 million individuals in the US holding onshore liquid assets
worth in excess of USD300k in 2003, compared to only 7.

narratives frameworks

Advocate also incorporates a unique methodology that enables the management
of thought leaders across several important objective parameters including
influence and advocacy.
Identifies the key competitors for those services and analyses the current
competitive environment in the US.1%.

interpretative regard

" This provides access to
critical business data at key points in the decision-making process.
The US market has seen a significant degree of M+A activity over the last
year, reflecting both the difficulties experienced during the past few years
and the current growth ambitions of some of the more successful players.

frameworks pursue

iAdvocate enables the management of key opinion leader initiatives across
three critical phases: planning, executing and measuring results. We feel that iAdvocate can give pharmaceutical companies a
strategic and competitive advantage in this critical area. One
the most active acquirers during 2004 has been Mellon , announcing a total of
five wealth management acquisitions.researchandmarkets.

emergent thus

com
Fax: +353 1 4100 980

increases reflexivity

Intelligration also provides the communication and workflow backbone necessary
to develop high-performance teams. Utilizing expert services, unique methodology and its
Intelligration (R) technology, Skila's solutions integrate critical information
communicating it to the right people , at the right time through a "Single Touch
Point.

converges pursue

newscom.

Reasons to Read
-- Identify how large the US wealth management market is and how much you
could gain by entering the market
-- Identify the key US wealth managers, where you fit in among them and
their current considerations with regard to competing in this market
-- Use the market sizing forecasts and key future trends to shape your US
wealth management strategy going forward

Contents include the following:-

CHAPTER 1 EXECUTIVE SUMMARY
Market context
Competitive dynamics
The future decoded
CHAPTER 2 INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
CHAPTER 3 MARKET CONTEXT
Introduction
Economic and financial drivers
The US High Net Worth market
Current size and composition
Historic growth
Regional income distribution
Data
Economic drivers
Market size
CHAPTER 4 COMPETITIVE DYNAMICS
Introduction
Key competitors
Competitive trends
Mergers and acquisitions
The emergence of a private banking model
From returns to risk assessment -- shifting client attitudes
Regulation
CHAPTER 5 THE FUTURE DECODED
Introduction
Forecasted market size and composition
Key future trends and issues
Data
CHAPTER 6 APPENDIX
Definitions
Research methodology

LIST OF TABLES

LIST OF FIGURES

For more information visit
http://www.

narratives discursive

iAdvocate utilizes
Skila's proprietary Intelligration (R) platform which integrates and prioritizes
multiple data sources into a "Single Touch Point.

reflexivity thus

MORRIS PLAINS, N.

Action research can be described as a family of research methodologies which pursue action (or change) and research (or understanding) at the same time.

refining intentions

, Skila, a Sela2 Company,
announces the launch of iAdvocate, a new, unique method for managing
pharmaceutical key opinion leader relationships . iAdvocate aims to rapidly grow advocacy levels by
optimizing execution, developing and quickly implementing best practices, and
continuously monitoring performance so that companies can quickly adjust to the
continuously changing marketplace.

Research and Markets: Gauging and Aggregating the Number of Onshore Liquid Assets of High Net Worth Individuals in the U.S. From 1998-2008 Across Five Asset Ba

Since 2003
however, the situation has improved and this report examines the recent
developments both in terms of market growth and competition to provide an
insight into this key market.com/reports/c18404

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets .

In most of its forms it is also participative (among other reasons, change is usually easier to achieve when those affected by the change are involved) and qualitative.

narratives distinguishing

Pharmaceutical companies are vitally interested in more effective
methods to manage these important relationships.3% over the next five years.

reflexivity illustrating

" These solutions are vital to pharmaceutical organizations in
successfully managing common business challenges such as:

-- Maximizing the impact of Strategic Alliances with marketing partners
-- Optimizing product launches
-- Maximizing effectiveness between marketing, sales, and medical teams
-- Maximizing share of mind with key Opinion Leaders
-- Synchronizing measurement and performance of Global Brand Teams

For more information , visit us at http://www. DUBLIN, Ireland, Research and Markets
(http://www.
Over the next five years the HNW population in the US is expected to grow
at a compound annual rate of 7.

discursive iterative

Pharmaceutical Solutions Provider - Skila - Launches iAdvocate - Targeted to Improve the Management of Opinion Leader Relationships

However, the market has yet to return to its five year high of 8.

continuously intentions

9m
individuals in 1999.

emergent construct

Current methods focus mainly
on simply mapping thought leader influence and building a database to store that
information. "Our mission is to provide best-in-class solutions that enable
pharmaceutical companies to uniquely respond to today's critical business
challenges.

frameworks methodologies

High-performance teams that are more agile
and more efficient have greater potential to drive effectiveness gains .

Scope
Sizes and forecasts the number and aggregate onshore liquid assets of high
net worth individuals in the US from 1998-2008 across five asset bands. The fastest growing liquid asset band is
expected to be that of USD3m+, the population of which will increase at a
compound rate of 10.

interpretative thus

participative iterative

The average pharmaceutical brand invests over $38 million on thought leader
development .com.3m individuals in 2002.

thus methodologies

iAdvocate is
also easily configurable to adapt to the individual requirements of each
customer's unique process.

In most of its forms it does this by
using a cyclic or spiral process which alternates between action and critical reflection and
in the later cycles, continuously refining methods, data and interpretation in the light of the understanding developed in the earlier cycles.

It is thus an emergent process which takes shape as understanding increases; it is an iterative process which converges towards a better understanding of what happens.

refining happens

"

About Skila
Skila is a customer-driven company and a leader in developing best-in-
class knowledge-driven management solutions for the pharmaceutical industry.